Search results
British Thoracic Society Guideline for bronchiectasis in adults Adam T Hill, 1 Anita L Sullivan,2 James D Chalmers,3 Anthony De Soyza,4 J Stuart Elborn,5 R Andres Floto,6,7 Lizzie Grillo,8 Kevin Gruffydd-Jones,9 Alex Harvey,10 Charles S Haworth,7 Edwin Hiscocks,11 John R Hurst,12 Christopher Johnson,7 W Peter Kelleher,13,14,15 Pallavi Bedi,16 Karen Payne,17
Treatment for bronchiectasis aims to reduce chest infections and symptoms, improve quality of life and lower a person’s likelihood of complications, like reduced lung function.
Reduced lung function, poor quality of life, respiratory failure and premature death may result and can be ameliorated by vigorous medical intervention, including early diagnosis, physiotherapy and appropriate antibiotic treatment of infective exacerbations.
28 gru 2018 · Use of bronchodilators in patients with bronchiectasis and coexisting COPD or asthma should follow the guideline recommendations for COPD or asthma (D). Offer a trial of long-acting bronchodilator therapy in patients with symptoms of significant breathlessness (D).
Chest pain remains a diagnostic challenge in the ED and outpatient setting and requires thorough clinical evaluation. • Although the cause of chest pain is often noncardiac, coronary artery disease
This is a guideline for the management of bronchiectasis in primary and secondary care. More information can be found on the British Thoracic Society guideline which is available here.
The ACC/AHA Joint Committee on Clinical Practice Guidelines has commissioned this guideline to focus on the evaluation of acute or stable chest pain or other anginal equivalents, in various clinical settings, with an emphasis on the diagnosis on ischemic causes.
